Adenosine Receptor Agonists & Antagonists

Product description

The present Competitive Intelligence Report about new developments in the pipeline of agonists and antagonists targeting the adenosine receptor provides a competitor evaluation in the field of R&D projects from preclinical stages up to advanced clinical development of Adenosine Receptor Agonists & Antagonists as of May 2008.

The report includes a compilation of current active projects in research and development of agonists and antagonists of the adenosine receptor subtypes 1, 2A, 2B and 3 used for treatment of a variety of diseases including cardiac arrhythmias, cardiac imaging (stress agent), acute and chronic heart failure, Parkinsons disease and many more. Among the competitors are Big Pharma as well as specialist companies including Biogen Idec, Pfizer, Merck, Schering-Plough and many more.

Competitor projects are listed in a tabular format providing Information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.